FDA Says Drug Approval Scheme May Stymie Generics
Some aspects of the drug approval process might have wrongfully blocked generic alternatives from entering the market, an issue that will be undertaken shortly at a public meeting, the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article